Anna E. Beaudin

Anna E. Beaudin is an Associate Professor in the Department of Internal Medicine at the University of Utah School of Medicine, holding an adjunct appointment in the Department of Pathology's Division of Microbiology and Immunology. Her research centers on fetal hematopoiesis and its lifelong impact on immune function and disease susceptibility.

Her educational background includes:

• B.A. from Cornell University
• M.S. from Brown University
• Ph.D. from Cornell University

Dr. Beaudin's work investigates how fetal hematopoietic stem cells generate specialized immune cells that persist into adulthood to maintain tissue homeostasis. She examines how prenatal challenges like infection and nutrition disrupt immune development, leading to conditions such as asthma, metabolic disorders, and hearing loss. Her lab employs single-cell analysis, fate-mapping, and mouse models to uncover mechanisms of developmental hematopoiesis.

Recent publications reveal a dominant theme: prenatal inflammation and nutritional factors reprogram hematopoietic stem cells, altering immune cell development and increasing susceptibility to allergic, metabolic, and autoimmune diseases across the lifespan. Key focus areas include tissue-resident macrophages, innate lymphoid cells, and fetal-specific hematopoietic pathways.

Her scientific recognition includes:

• Pew Biomedical Scholars Award
• Hellman Foundation Award

Research is supported by NIH grants and published in high-impact journals including Cell Stem Cell and Blood.

As Principal Investigator, she mentors graduate students through the Molecular Biology Program and serves on committees for the International Society of Experimental Hematology and American Society of Hematology. Her work involves extensive collaboration with immunologists, hematologists, and developmental biologists.

The Beaudin Lab operates within the University of Utah's Molecular Medicine Program, utilizing advanced genomic and in vivo techniques to explore how early-life events shape lifelong immunity and disease risk.